Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis

Inflamm Bowel Dis. 2017 Jan;23(1):E5-E6. doi: 10.1097/MIB.0000000000000992.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Colitis, Ulcerative / surgery*
  • Drug Resistance, Microbial
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pouchitis / drug therapy*
  • Pouchitis / etiology
  • Proctocolectomy, Restorative / adverse effects*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • vedolizumab